Bladder adenocarcinoma is a histological variant that only represents 0.5-2% of cases. The bladder cancer is expected to affect one in 27 men and one in 89 women over the course of their lifetime, with a lifetime risk of approximately 2.2% in the general population in the united states. The bladder can develop primary or secondary adenocarcinomas, with secondary adenocarcinomas being more frequent than primary adenocarcinomas. The primary bladder adenocarcinoma falls into two broad categories: urachal and non-urachal. Patients with non- urachal primary bladder adenocarcinoma appear to have a worse prognosis than those with urachal adenocarcinoma. It is essential to know better about the diagnosis, current treatment and prognosis of the primary bladder adenocarcinoma. Here we describe the article review regarding the primary bladder adenocarcinoma
Author Biographies
Badrul Islamy
Internship at Sekotong Public Health Centre, West Lombok, West Nusa Tenggara, Indonesia
Akhada Maulana
Staff Division of Urology/Department of Surgery, Faculty of Medicine Mataram University/West Nusa Tenggara Province General Hospital, Mataram, West Nusa Tenggara, Indonesia
Made Kresna Yudhistira Wiratma
Resident Division of Urology, Department of Surgery, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University, Dr. Sardjito Hospital, Yogyakarta, Indonesia
